Ryman Healthcare Limited (NZX:RYM) Annual Report 2026



The latest annual report of Ryman Healthcare Limited (RYM) was published on 31 Mar 2026. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - RYM Annual Results

Amounts in NZD

Total Revenue
$855.59M
Gross Profit
$80.78M
EBIT
$45.52M
Net Tangible Assets
$4.08B
Net Income
$-171.30M
Capital Expenditures
-

RYM Income Statement 2026 Annual Report

As per the latest Income Statement of RYM, the Net revenue increased by $94.89M (12%) compared to the previous period. The operating income in 2026 increased by - (-). The net income as per the annual report was $-171.30M which increased by $265.50M (61%) compared to previous year.

Income Statement Report (2026/2025)

2026 2025
Total Revenue $855.59M $760.70M
Gross Profit $80.78M $80.78M
Operating Income - -
Income Before Tax - -
Net Income $-171.30M $-436.80M

Balance Sheet - RYM 2026 Annual Report

Read further: RYM Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Ryman Healthcare Limited showed the company increased the cash on balance sheet by $0.00 (0%). The Net tangible assets of RYM on the balance sheet were at $4.08B which is $0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2026/2025)

2026 2025
Cash $20.29M $20.29M
Total Assets - -
Long Term Debt - -
Total Liabilities $7.76B $7.76B
Total Shareholder Equity - -
Net Tangible Assets $4.08B $4.08B

Cash Flow Statement - RYM 2026 Annual Report

The 2026 annual cash flow statement of Ryman Healthcare Limited showed that the net income increased by $265.50M (61%) compared to previous reporting period. Also the capital expenditure of RYM increased by - (-).

As of 2026, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2026/2025)

2026 2025
Net Income $-171.30M $-436.80M
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

Ryman Healthcare Limited Annual Report History

Income Statement

Income Statement history of Ryman Healthcare Limited (NZX:RYM)

31 Mar 2026 31 Mar 2025 31 Mar 2024 31 Mar 2023
Total Revenue $855.59M $760.70M $689.89M $570.98M
Cost Of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses $0.00 $0.00 $0.00 $0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit $0.00 $0.00 $0.00 $0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income $-171.30M $-436.80M $4.78M $257.84M
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of Ryman Healthcare Limited (NZX:RYM)

31 Mar 2026 31 Mar 2025 31 Mar 2024 31 Mar 2023
Cash $20.29M $20.29M - -
Total Assets - - - -
Total Liab $7.76B $7.76B - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets $4.08B $4.08B - -

Cash Flow Statement

Cash Flow Statement history of Ryman Healthcare Limited (NZX:RYM)

31 Mar 2026 31 Mar 2025 31 Mar 2024 31 Mar 2023
Net Income $-171.30M $-436.80M - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -